INTECH Investment Management’s Immunovant IMVT Stock Holding History

INTECH Investment Management’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$881K	Sell	22,865 -7,114	-24%	-$217K	0.01%	1096
2026 Q1	$745K	Sell	29,979 -5,210	-15%	-$135K	0.01%	1147
2025 Q4	$895K	Buy	35,189 +4,039	+13%	+$90.1K	0.01%	1189
2025 Q3	$502K	Sell	31,150 -14,200	-31%	-$230K	﹤0.01%	1577
2025 Q2	$726K	Sell	45,350 -625	-1%	-$9.45K	0.01%	1391
2025 Q1	$786K	Buy	45,975 +14,536	+46%	+$304K	0.01%	1350
2024 Q4	$779K	Buy	31,439 +9,614	+44%	+$273K	0.01%	1302
2024 Q3	$622K	Buy	+21,825	New	+$644K	0.01%	1109

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

INTECH Investment Management's IMVT Position: Q2 2026 in Review

INTECH Investment Management reduced its Immunovant (IMVT) stake by 24% in Q2 2026, selling an estimated $217K and leaving 22,865 shares worth $881K. The position accounts for 0.01% of the portfolio, ranked #1096.

INTECH Investment Management first reported a position in IMVT in Q3 2024 and has held it in 8 quarters since. The position peaked at $895K in Q4 2025. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

INTECH Investment Management held 22,865 shares of Immunovant worth $881K as of Q2 2026.
INTECH Investment Management sold 7,114 Immunovant shares in Q2 2026, an estimated $217K.
Immunovant made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1096 holding.
INTECH Investment Management first reported a position in Immunovant in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Immunovant position peaked at $895K in Q4 2025.
226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.